Biofrontera
BFRIW
5 hedge funds and large institutions have $136K invested in Biofrontera in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.28% less ownership
Funds ownership: 1.94% → 1.66% (-0.28%)
17% less funds holding
Funds holding: 6 → 5 (-1)
42% less capital invested
Capital invested by funds: $236K → $136K (-$100K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$268 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$10K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.06K |
BFRIW Hedge Fund Activity: Q3 2022 in Review
5 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q3 2022, worth a combined $136K — down 42% from $236K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $268. The largest seller was Warberg Asset Management, exiting entirely with an estimated $10K sold.
- 5 institutional investors held Biofrontera (BFRIW) as of Q3 2022, down from 6 in Q2 2022.
- Funds reported $136K of Biofrontera stock for Q3 2022, down 42% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Biofrontera buyer in Q3 2022 was UBS Group, an estimated $268 added.
- The largest Biofrontera seller in Q3 2022 was Warberg Asset Management, an estimated $10K sold.
Based on aggregated 13F filings for Q3 2022.